WO2025167739 - USE OF COMPOUND IN PREPARING DRUG FOR PREVENTING AND/OR TREATING MOUNTAIN SICKNESS

National phase entry is expected:
Publication Number WO/2025/167739
Publication Date 14.08.2025
International Application No. PCT/CN2025/074694
International Filing Date 24.01.2025
Title **
[English] USE OF COMPOUND IN PREPARING DRUG FOR PREVENTING AND/OR TREATING MOUNTAIN SICKNESS
[French] UTILISATION D'UN COMPOSÉ DANS LA PRÉPARATION D'UN MÉDICAMENT POUR LA PRÉVENTION ET/OU LE TRAITEMENT DU MAL DES MONTAGNES
[Chinese] 化合物在制备预防和/或治疗高原病的药物中的应用
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
XIAO, Ying
DUAN, Zhenfang
ZHANG, Ruijie
MU, Shengmei
GENG, Lei
XING, Yan
Priority Data
202410166200.8   05.02.2024   CN
202410438804.3   11.04.2024   CN
202410708046.2   31.05.2024   CN
202411425722.1   12.10.2024   CN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1742
EPO Filing, Examination, Granting11777
Japan Filing, Examination, Granting1947
South Korea Filing, Examination, Granting1679
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 21,885
Contact Us
Abstract[English] Use of a compound and a pharmaceutical composition thereof in preparing a drug for preventing and/or treating mountain sickness. The compound is N-[7-hydroxy-5-(2-phenylethyl)[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]glycine.[French] L'invention concerne l'utilisation d'un composé et d'une composition pharmaceutique de celui-ci dans la préparation d'un médicament pour la prévention et/ou le traitement du mal des montagnes. Le composé est la N-[7-hydroxy-5-(2-phényléthyl)[1,2,4] triazolo[1,5-a]pyridine-8-carbonyl]glycine.[Chinese] 化合物及其药物组合物在制备预防和/或治疗高原病的药物中的应用,其中,所述化合物是N-[7-羟基-5-(2-苯乙基)[1,2,4]三唑[1,5-a]吡啶-8-羰基]甘氨酸。

Rejoining the server...